Drug Cos. Say Loestrin Buyers Trying To Expand Actavis
Lupin Pharmaceuticals Inc. and Allergan PLC told the First Circuit Friday that Loestrin buyers were trying to turn the U.S. Supreme Court's ruling allowing pay-for-delay deals to face antitrust scrutiny into...To view the full article, register now.
Already a subscriber? Click here to view full article